Stevanato Group SpA
Suletud
SektorTervishoid
20.8 -0.48
Ülevaade
Aktsiahinna muutus
24h
Min
20.42
Max
21.14
Sissetulek | -1.1M 38M |
|---|---|
Müük | 28M 302M |
P/E Sektori keskmine | 35.983 56.597 |
Aktsiakasum | 0.16 |
Kasumimarginaal | 12.622 |
Töötajad | 6,010 |
EBITDA | -25M 40M |
Järgmine tulemuste avaldamine | 5. nov 2026 |
|---|
Turukapital | -19M 5.6B |
|---|---|
Eelmine avamishind | 21.28 |
Eelmine sulgemishind | 20.8 |
Uudiste sentiment
By Acuity
50%
50%
136 / 339 Pingereas Healthcare
Stevanato Group SpA Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Stevanato Group SpA Prognoos
Sentiment
By Acuity
136 / 339 Pingereas Tervishoid
Uudiste sentiment
Neutral
Volatiilsus
Alla keskmise
Uudismaht (RCV)
Keskmine
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Stevanato Group SpA
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.